LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
动量输入（同类管理人）：
持有人广度 +9.1% ·
股份流向 -2.3% ·
净新建仓位 +8.3%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 193 | +4 | 671.92M | $804.91B | +6 | −1 |
| Q1 2026 | 191 | -3 | 666.59M | $613.20B | +1 | −5 |
| Q4 2025 | 193 | +2 | 707.04M | $758.81B | +3 | — |
| Q3 2025 | 27 | -3 | 329.88M | $251.63B | +2 | −6 |
| Q2 2025 | 28 | -1 | 307.45M | $239.60B | +2 | −3 |
| Q1 2025 | 26 | 0 | 140.32M | $115.83B | +1 | −1 |
| Q4 2024 | 26 | +1 | 145.00M | $111.91B | +3 | −2 |
| Q3 2024 | 24 | +2 | 109.89M | $97.29B | +2 | — |
| Q2 2024 | 22 | — | 112.43M | $101.75B | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 20.93M | +1.4% | $18.54B | 2.1% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 20.93M | +1.4% | $18.54B | 2.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Capital World Investors ✦ | 20.36M | -6.7% | $18.03B | 2.8% | ▼ Trim | 2 | SEC ↗ |
| 4 | PRIMECAP Management ✦ | 17.69M | -9.8% | $15.67B | 11.5% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 17.09M | +0.5% | $15.09B | 1.2% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 17.09M | +0.5% | $15.09B | 1.2% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 10.61M | -1.5% | $9.40B | 1.6% | ▼ Trim | 2 | SEC ↗ |
| 16 | Norges Bank ✦ (被动) | 10.49M | -4.7% | $9.29B | 1.3% | ▼ Trim | 2 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 5.06M | +3.5% | $4.48B | 1.8% | ▲ Add | 2 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 1.63M | +1.3% | $1.44B | 1.2% | ▲ Add | 2 | SEC ↗ |
| 19 | Millennium Management ✦ | 990.21K | +86.1% | $877.27M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 20 | Tiger Global Management ✦ | 969.80K | +4.3% | $859.18M | 3.7% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 910.13K | +15.3% | $806.32M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 22 | Marshall Wace ✦ | 910.13K | +15.3% | $806.32M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 23 | Marshall Wace ✦ | 910.13K | +15.3% | $806.32M | 1.1% | ▲ Add | 2 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 829.38K | +0.2% | $734.78M | 1.3% | ▲ Add | 2 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 677.64K | +42.8% | $591.79M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 677.64K | +42.8% | $591.79M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 677.64K | +42.8% | $591.79M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 677.64K | +42.8% | $591.79M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 677.64K | +42.8% | $591.79M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 408.08K | +72.0% | $361.54M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 408.08K | +72.0% | $361.54M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 32 | Renaissance Technologies ✦ | 257.81K | 新增 | $228.41M | 0.3% | New | 1 | SEC ↗ |
| 33 | Coatue Management ✦ | 247.95K | +19.8% | $219.67M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 34 | Coatue Management ✦ | 247.95K | +19.8% | $219.67M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 35 | Coatue Management ✦ | 247.95K | +19.8% | $219.67M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 36 | Coatue Management ✦ | 247.95K | +19.8% | $219.67M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 37 | Coatue Management ✦ | 247.95K | +19.8% | $219.67M | 0.8% | ▲ Add | 2 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 215.18K | -57.0% | $190.64M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 215.18K | -57.0% | $190.64M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 40 | Two Sigma Investments ✦ | 199.74K | -11.5% | $176.95M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 41 | Viking Global Investors ✦ | 152.04K | +5.5% | $134.70M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 42 | Bridgewater Associates ✦ | 73.27K | -23.5% | $64.91M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 43 | Dodge & Cox ✦ | 45.09K | -1.9% | $39.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 44 | GAMCO Investors ✦ | 34.81K | -2.8% | $30.84M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 45 | Point72 Asset Management ✦ | 13.16K | 新增 | $11.66M | 0.0% | New | 1 | SEC ↗ |
| 46 | Gotham Asset Management ✦ | 8.52K | -28.7% | $7.54M | 0.1% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $228.41M | 0.3% |
| Point72 Asset Management | $11.66M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 4,323 持有人, 762.84M 股份, $674.93B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 6.50K 股 · $7.64M
Officer · 2.00K 股 · $2.37M
Officer · 5.00K 股 · $5.95M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…
ForbesThe Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…
WSJThe U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help identify signs of…
ReutersThe once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…
WSJEli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight management and type 2…
Reuters